These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 20513372)
1. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy. Köhler C; Bista P; Götz J; Schröder H Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372 [TBL] [Abstract][Full Text] [Related]
2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
3. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy. Sydow A; Mandelkow EM Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454 [TBL] [Abstract][Full Text] [Related]
4. Divergent phosphorylation pattern of tau in P301L tau transgenic mice. Deters N; Ittner LM; Götz J Eur J Neurosci; 2008 Jul; 28(1):137-47. PubMed ID: 18662339 [TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182 [TBL] [Abstract][Full Text] [Related]
6. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695 [TBL] [Abstract][Full Text] [Related]
7. Fas-associated factor 1 promotes in neurofibrillary tangle-mediated cell death of basal forebrain cholinergic neurons in P301L transgenic mice. Kim JM; Kim SS; Lee YD Neuroreport; 2015 Sep; 26(13):767-72. PubMed ID: 26164610 [TBL] [Abstract][Full Text] [Related]
8. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317 [TBL] [Abstract][Full Text] [Related]
9. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice. Kambe T; Motoi Y; Inoue R; Kojima N; Tada N; Kimura T; Sahara N; Yamashita S; Mizoroki T; Takashima A; Shimada K; Ishiguro K; Mizuma H; Onoe H; Mizuno Y; Hattori N Neurobiol Dis; 2011 Jun; 42(3):404-14. PubMed ID: 21324362 [TBL] [Abstract][Full Text] [Related]
10. Pattern of tau hyperphosphorylation and neurotransmitter markers in the brainstem of senescent tau filament forming transgenic mice. Morcinek K; Köhler C; Götz J; Schröder H Brain Res; 2013 Feb; 1497():73-84. PubMed ID: 23261664 [TBL] [Abstract][Full Text] [Related]
11. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Zhang Q; Zhang X; Sun A Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690 [TBL] [Abstract][Full Text] [Related]
13. Substrate-specific reduction of PP2A activity exaggerates tau pathology. Deters N; Ittner LM; Götz J Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401 [TBL] [Abstract][Full Text] [Related]
14. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993 [TBL] [Abstract][Full Text] [Related]
15. Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau. Ren Y; Lin WL; Sanchez L; Ceballos C; Polydoro M; Spires-Jones TL; Hyman BT; Dickson DW; Sahara N J Alzheimers Dis; 2014; 38(3):589-600. PubMed ID: 24028867 [TBL] [Abstract][Full Text] [Related]
17. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359 [TBL] [Abstract][Full Text] [Related]
19. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841 [TBL] [Abstract][Full Text] [Related]